SCHEMBL22178208

SCHEMBL22178208

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccccc5)c4)nc(-c4cccc5sc6c(-c7nc8ccccc8o7)cccc6c45)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HPGD P15428 5/20 0.41
MAPT P10636 5/20 0.41
KDM4E B2RXH2 4/20 0.41
USP2 O75604 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 6/20 0.39
TP53 P04637 4/20 0.39
RAB9A P51151 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 1/20 0.39
NFKB1 P19838 1/20 0.39
STAT1 P42224 1/20 0.39
GFER P55789 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
PTGS2 P35354 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22177737 0.99 MAPT (0.42) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177736 0.96 ALDH1A1 (0.42) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22178209 0.96 ALDH1A1 (0.42) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177813 0.95 MAPT (0.42) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177739 0.94 ALDH1A1 (0.43) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177812 0.93 MAPT (0.41) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177381 0.92 MAPT (0.40) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177360 0.92 MAPT (0.40) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177384 0.92 MAPT (0.40) ALDH1A1HPGDMAPTKDM4EUSP2
SCHEMBL22177385 0.92 ALDH1A1 (0.43) ALDH1A1HPGDMAPTKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same LG CHEM, LTD. (KR) 2022-12-06 US disclosed
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, CYP1A1 ALDH1A1 18/4885HPGD 913/4885MAPT 1997/4885
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same CRY1, CYP1A1, CRY2 ALDH1A1 16/4885HPGD 485/4885MAPT 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.